CME in Minutes: Education in Dermatology
By Answers in CME
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Answers in CME
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 3
Reviews: 0
Episodes: 48
Description
Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Dermatology by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for dermatologists to cover the diagnosis, treatment, follow-up, and clinical management of various skin conditions. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.
| Episode | Date |
|---|---|
|
Sheilagh M. Maguiness, MD, FAAP / Elizabeth Vainder, MD, FAAP - Escalating Atopic Dermatitis Treatment in Pediatric Patients With Confidence: What Do the Guidelines Tell Us?
|
Dec 10, 2025 |
|
Tina Bhutani, MD, MAS, FAAD / Robin K. Dore, MD - The Dermatology-Rheumatology Psoriatic Playbook: Advancing Care With Novel Oral Therapies in the Evolving PsA Landscape
|
Dec 09, 2025 |
|
April W. Armstrong, MD, MPH / Linda Stein Gold, MD / Clive M. Liu, MD - Personalizing Psoriasis Care Across the Map: Navigating Regional Barriers to Integrating Oral Small Molecule Treatment for Moderate to Severe Disease
|
Dec 03, 2025 |
|
Michael Postow, MD - Enhancing First-Line Treatment Selection in Advanced Melanoma: A Patient-Centered Approach
|
Dec 02, 2025 |
|
Terry Faleye, MPAS, PA-C / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing Care
|
Nov 19, 2025 |
|
Arielle Elkrief, MD - Navigating Neoadjuvant, Adjuvant, and Perioperative Immunotherapy in Resectable High-Risk Melanoma: Tailoring Care for Optimal Outcomes
|
Nov 18, 2025 |
|
Linda Stein Gold, MD / April W. Armstrong, MD, MPH / Erin Boh, MD, PhD - Personalizing Psoriasis Care Across the Map: Navigating Regional Barriers to Integrating Oral Small Molecule Treatment for Moderate to Severe Disease
|
Nov 07, 2025 |
|
Nikhil I. Khushalani, MD - From Trial to Team: Optimizing Adjuvant Immunotherapy for High-Risk Cutaneous Squamous Cell Carcinoma
|
Sep 22, 2025 |
|
April W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Next-Generation Treatments for Moderate-to-Severe Plaque Psoriasis: What's New in TYK2
|
Aug 04, 2025 |
|
Neil D. Gross, MD, FACS - Evolving the Multi-Modal Approach for Resectable Cutaneous Squamous Cell Carcinoma: A Multidisciplinary Assessment of Current and Emerging Immunotherapeutic Strategies
|
Jul 11, 2025 |
|
Hussein Tawbi, MD, PhD - Evolving Melanoma Care: The Clinical Impact of Anti-LAG-3/PD-1 Combinations
|
Jul 07, 2025 |
|
Emma Guttman-Yassky, MD, PhD - Taking a New Approach to Relieving Atopic Dermatitis: The Evidence for OX40/OX40L Therapies
|
May 29, 2025 |
|
Nathan Falk, MD, MBA, FAAFP - Making Sense of Type 2 Inflammation Crosstalk in Chronic Diseases: Perspectives on Improving Emergency and Primary Care Collaboration
|
Apr 02, 2025 |
|
Sunandana Chandra, MD, MS - Practical Guidance on Managing Adverse Events Associated With Immunotherapy Regimens for Nonmelanoma Skin Cancers
|
Dec 17, 2024 |
|
Erin Barrett (Wei), MD - Focusing on the Patient to Enhance Therapeutic Care: Advancing Early Diagnosis and Management of Bullous Pemphigoid
|
Nov 29, 2024 |
|
Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice
|
Nov 06, 2024 |
|
Vishal A. Patel, MD - Selecting and Sequencing Systemic Treatment for Advanced Basal Cell Carcinoma
|
Oct 28, 2024 |
|
Ahmad Tarhini, MD, PhD - Adjuvant Approaches in High-Risk, Resectable Melanoma: A Practical Guide to Improving Outcomes With Immunotherapy-Based Regimens
|
Sep 19, 2024 |
|
David M. Miller, MD, PhD / Todd Schlesinger, MD - A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies
|
Sep 13, 2024 |
|
Vasu Divi, MD, MS - Neoadjuvant Immunotherapy for CSCC: Practical Considerations for Resectability, Patient Selection, and Treatment Optimization
|
Sep 09, 2024 |
|
Vibeke Strand, MD / April W. Armstrong, MD, MPH - A New Take on TYK2 Inhibitors: Bridging Gaps in Psoriatic Arthritis Management With Novel Targeted Therapies
|
Sep 04, 2024 |
|
Cecelia Damask, DO - Evidence-Based Approaches to Sequencing and Switching Biologic Therapies in Patients With CRSwNP and Comorbidities
|
Aug 16, 2024 |
|
Jonathan Silverberg, MD, PhD, MPH - Taking a Hands-On Approach to the Management of Moderate to Severe Hand and Foot Atopic Dermatitis: Enhancing Patient Outcomes With Novel Systemic Therapies
|
Jul 04, 2024 |
|
Peter Lio, MD - AI in Healthcare: A Primer for the Practicing Clinician
|
Apr 05, 2024 |
|
Peter Lio, MD - Generative AI: Benefits for Your Practice, for Your Patients
|
Apr 05, 2024 |
|
Nikhil I. Khushalani, MD - Pointing the Way to Enhanced Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Practical Strategies to Incorporate Neoadjuvant Immunotherapy
|
Feb 26, 2024 |
|
Evan J. Lipson, MD - Real Talk About Maximizing Care in Advanced Melanoma: Balancing Benefit and Risk Using Dual Immunotherapy Regimens
|
Feb 14, 2024 |
|
Jonathan Barker, BSc, MB, BS, MD, FRCP - Novel Approved and Emerging IL-36 Receptor Inhibitors for the Treatment of GPP
|
Jan 26, 2024 |
|
David M. Miller, MD, PhD / Kevin Emerick, MD - Coming Together to Improve Outcomes in Resectable Cutaneous Squamous Cell Carcinoma: Multidisciplinary Care Strategies With Neoadjuvant Immunotherapy
|
Jan 03, 2024 |
|
Vishal A. Patel, MD - Making Headway in Treating Resectable Cutaneous Squamous Cell Carcinoma: Setting Sights on Neoadjuvant Immunotherapy
|
Dec 18, 2023 |
|
Trisha Wise-Draper, MD, PhD - Empowering Precision Decisions: PD-1 Inhibitor-Based Therapies and Biomarker Testing in R/M HNSCC
|
Oct 11, 2023 |
|
Shawn Kwatra, MD - Itching for Relief: Exploring the Role of Novel Biologics in Prurigo Nodularis
|
Oct 06, 2023 |
|
Sapna P. Patel, MD - Enhancing Neoadjuvant and Adjuvant Treatment in Resectable Melanoma: Is Timing the Key to Improved Outcomes?
|
Sep 19, 2023 |
|
Peter Lio, MD - Enriching Care for Pediatric Atopic Dermatitis: Evidence-Based Strategies for Integrating Targeted Systemic Therapies
|
Aug 23, 2023 |
|
April W. Armstrong, MD, MPH - Looking Ahead: What the Future Holds for Novel Systemic Therapies in the Treatment of Moderate-to-Severe Atopic Hand and Foot Dermatitis
|
Jul 03, 2023 |
|
Axel Hauschild, MD - Advancing Outcomes in Surgically Resectable Cutaneous Squamous Cell Carcinoma: Carving New Paths Forward With Immunotherapies
|
Jun 15, 2023 |
|
Dirk Schadendorf, MD - An Evolution in Care for Advanced Melanoma: Exploring the Clinical Implications of Approved and Emerging Anti–LAG-3/PD-1 Combinations
|
Jun 08, 2023 |
|
Hussein Tawbi, MD, PhD / Laura K. Ferris, MD, PhD - Optimizing Outcomes in Advanced Melanoma Through Enhanced Collaboration: A Real-World Multidisciplinary Approach
|
May 04, 2023 |
|
Reinhard Dummer, Prof. Dr. med - Making the Case for a Systemic Approach to Advanced Basal Cell Carcinoma: A Multidisciplinary Team Strategy to Optimize Long-Term Care
|
Mar 30, 2023 |
|
Brian S. Kim, MD - Scratching the Itch: Biologic Breakthroughs in Prurigo Nodularis
|
Mar 16, 2023 |
|
Bruce E. Strober, MD, PhD - Patient Conversations in Plaque Psoriasis: Discussing Novel TYK2 Inhibitors for the Treatment of Patients Who Are Candidates for Systemic Therapy
|
Mar 16, 2023 |
|
Omid Hamid, MD - An Expert Conversation About Anti-LAG-3/PD-1 Combinations: Exploring the Clinical Impact of Approved and Emerging Combinations in the Advanced Melanoma Treatment Landscape
|
Dec 20, 2022 |
|
Todd Schlesinger, MD, FAAD - Optimizing Immunotherapy in Patients With Advanced Basal Cell Carcinoma: Practical Strategies to Inform Care
|
Dec 13, 2022 |
|
Peter Lio, MD - More Than Scratching the Surface: Optimizing Novel JAK Inhibitors for Improved Outcomes in Moderate-to-Severe Atopic Dermatitis
|
Dec 05, 2022 |
|
Latanya Benjamin, MD, FAAD, FAAP - Improving the Care of Children with Moderate-to-Severe Atopic Dermatitis: When and How to Intensify Treatment with Novel Systemic Agents
|
Nov 16, 2022 |
|
Tanios Bekaii-Saab, MD / Beth McLellan, MD - Managing Hand-Foot Skin Reaction: Interdisciplinary Strategies for Patients on Multikinase Inhibitors
|
Oct 04, 2022 |
|
Ikuo Hirano, MD - Closing In on Improved Quality of Life for Patients With Eosinophilic Esophagitis by Diagnosing Promptly and Understanding Type 2 Inflammation
|
Sep 26, 2022 |
|
Peter Lio, MD - Clinical Perspective on the Latest Data for Emerging Therapies Targeting IL-13 in Moderate-to-Severe Atopic Dermatitis
|
Sep 02, 2022 |